Burning Rock Biotech Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$11.01 | -$11.01 | -$11.01 |
| Q2 2024 | 0 | -$10.80 | -$10.80 | -$10.80 |
| Q3 2024 | 0 | -$9.91 | -$9.91 | -$9.91 |
| Q4 2024 | 0 | -$10.34 | -$10.34 | -$10.34 |
Burning Rock Biotech Limited Earnings Date And Information
Burning Rock Biotech Limited last posted its earnings results on Tuesday, May 30th, 2023. The company reported $-2.6 earnings per share for the quarter, missing analysts' consensus estimates of $-2 by $0.6. The company had revenue of 135.53 M for the quarter and had revenue of 537.44 M for the year. Burning Rock Biotech Limited has generated $-6 earnings per share over the last year ($-6.38 diluted earnings per share) and currently has a price-to-earnings ratio of -0.47. Burning Rock Biotech Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Burning Rock Biotech Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/29/2024 | Q2 2024 | -$10.53 | $135.53 M | $135.53 M | ||
| 03/28/2024 | Q1 2024 | -$11.85 | $125.62 M | $125.62 M | ||
| 11/30/2023 | Q4 2023 | -$1.58 | $121.09 M | |||
| 09/05/2023 | Q3 2023 | -$1.71 | $198.02 M | $127.57 M | ||
| 05/30/2023 | Q2 2023 | -$2.00 | -$1.28 | 0.72 | $172.74 M | $146.27 M |
| 03/28/2023 | Q1 2023 | -$0.38 | -$1.81 | -1.43 | $142.52 M | |
| 11/16/2022 | Q4 2022 | -$2.11 | $142.24 M | |||
| 08/31/2022 | Q3 2022 | -$3.60 | -$2.18 | 1.42 | $154.05 M | $154.63 M |
| 05/31/2022 | Q2 2022 | -$2.30 | -$2.50 | -0.2 | $151.98 M | $130.85 M |
| 03/22/2022 | Q1 2022 | -$2.47 | $138.59 M | $135.52 M | ||
| 11/16/2021 | Q4 2021 | -$2.40 | $136.75 M | $147.35 M | ||
| 08/31/2021 | Q3 2021 | -$1.50 | -$1.64 | -0.14 | $129.08 M | $126.62 M |
| 05/25/2021 | Q2 2021 | -$1.40 | -$1.96 | -0.56 | $139.09 M | $127.28 M |
| 03/11/2021 | Q1 2021 | -$1.65 | $126.07 M | $106.62 M | ||
| 11/20/2020 | Q4 2020 | -$1.10 | -$1.51 | -0.41 | $124.83 M | $131.72 M |
| 08/11/2020 | Q3 2020 | -$2.00 | -$1.22 | 0.78 | $115.51 M | $123.88 M |
| 08/11/2020 | Q2 2020 | -$2.00 | -$1.74 | 0.26 | $94.18 M | $106.97 M |
| 03/30/2020 | Q1 2020 | -$0.52 | $67.33 M | |||
| 12/30/2019 | Q4 2019 | -$1.10 | $88.68 M | |||
| 09/29/2019 | Q3 2019 | -$0.37 | $103.72 M |
Burning Rock Biotech Limited Earnings: Frequently Asked Questions
-
When is Burning Rock Biotech Limited's earnings date?
Burning Rock Biotech Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Burning Rock Biotech Limited's earnings conference call?
The conference call for Burning Rock Biotech Limited's latest earnings report can be listened to online.
-
How can I read Burning Rock Biotech Limited's conference call transcript?
The conference call transcript for Burning Rock Biotech Limited's latest earnings report can be read online.
-
How much revenue does Burning Rock Biotech Limited generate each year?
Burning Rock Biotech Limited (:BNR) has a recorded annual revenue of $537.44 M.
-
How much profit does Burning Rock Biotech Limited generate each year?
Burning Rock Biotech Limited (:BNR) has a recorded net income of $537.44 M. Burning Rock Biotech Limited has generated $-6.38 earnings per share over the last four quarters.
-
What is Burning Rock Biotech Limited's price-to-earnings ratio?
Burning Rock Biotech Limited (:BNR) has a price-to-earnings ratio of -0.47 and price/earnings-to-growth ratio is -0.01.
